Matches in Wikidata for { <http://www.wikidata.org/entity/Q90874109> ?p ?o ?g. }
- Q90874109 description "2018 nî lūn-bûn" @default.
- Q90874109 description "2018年の論文" @default.
- Q90874109 description "2018年学术文章" @default.
- Q90874109 description "2018年学术文章" @default.
- Q90874109 description "2018年学术文章" @default.
- Q90874109 description "2018年学术文章" @default.
- Q90874109 description "2018年学术文章" @default.
- Q90874109 description "2018年学术文章" @default.
- Q90874109 description "2018年學術文章" @default.
- Q90874109 description "2018年學術文章" @default.
- Q90874109 description "2018年學術文章" @default.
- Q90874109 description "2018年學術文章" @default.
- Q90874109 description "2018年學術文章" @default.
- Q90874109 description "2018년 논문" @default.
- Q90874109 description "article científic" @default.
- Q90874109 description "article scientific" @default.
- Q90874109 description "article scientifique" @default.
- Q90874109 description "articol științific" @default.
- Q90874109 description "articolo scientifico" @default.
- Q90874109 description "artigo científico" @default.
- Q90874109 description "artigo científico" @default.
- Q90874109 description "artigo científico" @default.
- Q90874109 description "artikel ilmiah" @default.
- Q90874109 description "artikull shkencor" @default.
- Q90874109 description "artikulong pang-agham" @default.
- Q90874109 description "artykuł naukowy" @default.
- Q90874109 description "artículo científico publicado en 2018" @default.
- Q90874109 description "artículu científicu" @default.
- Q90874109 description "bilimsel makale" @default.
- Q90874109 description "bài báo khoa học" @default.
- Q90874109 description "naučni članak" @default.
- Q90874109 description "scienca artikolo" @default.
- Q90874109 description "scientific article published on 07 August 2018" @default.
- Q90874109 description "scientific article published on 7 August 2018" @default.
- Q90874109 description "scientific article published on 7 August 2018" @default.
- Q90874109 description "teaduslik artikkel" @default.
- Q90874109 description "tieteellinen artikkeli" @default.
- Q90874109 description "tudományos cikk" @default.
- Q90874109 description "vedecký článok" @default.
- Q90874109 description "vetenskaplig artikel" @default.
- Q90874109 description "videnskabelig artikel udgivet 7. august 2018" @default.
- Q90874109 description "vitenskapelig artikkel" @default.
- Q90874109 description "vitskapeleg artikkel" @default.
- Q90874109 description "vědecký článek" @default.
- Q90874109 description "wetenschappelijk artikel" @default.
- Q90874109 description "wissenschaftlicher Artikel" @default.
- Q90874109 description "επιστημονικό άρθρο" @default.
- Q90874109 description "мақолаи илмӣ" @default.
- Q90874109 description "наукова стаття, опублікована в серпні 2018" @default.
- Q90874109 description "научна статия" @default.
- Q90874109 description "научная статья" @default.
- Q90874109 description "научни чланак" @default.
- Q90874109 description "научни чланак" @default.
- Q90874109 description "מאמר מדעי" @default.
- Q90874109 description "مقالة علمية نشرت في 7 أغسطس 2018" @default.
- Q90874109 description "৭ আগস্ট ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q90874109 description "บทความทางวิทยาศาสตร์" @default.
- Q90874109 description "სამეცნიერო სტატია" @default.
- Q90874109 name "Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial" @default.
- Q90874109 name "Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial" @default.
- Q90874109 type Item @default.
- Q90874109 label "Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial" @default.
- Q90874109 label "Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial" @default.
- Q90874109 prefLabel "Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial" @default.
- Q90874109 prefLabel "Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial" @default.
- Q90874109 P1433 Q90874109-CA7A388E-0E51-47E3-88E6-6B7F4B56E1D0 @default.
- Q90874109 P1476 Q90874109-699B6F0A-B0C1-456C-B819-3240535A58A0 @default.
- Q90874109 P2093 Q90874109-09E7EAF7-E9A1-40F3-832B-18CD37C907C4 @default.
- Q90874109 P2093 Q90874109-26782B8A-333C-4C03-B1C6-DADEE5A755F8 @default.
- Q90874109 P2093 Q90874109-2D238791-C091-4F07-98BE-874E7106EDA2 @default.
- Q90874109 P2093 Q90874109-42A1E138-9C40-4B5A-8413-A2BB2BE505A3 @default.
- Q90874109 P2093 Q90874109-4364BA0D-6B9A-4CEF-8A0E-36458DF06E43 @default.
- Q90874109 P2093 Q90874109-50F662BF-2ADD-426B-A9FF-B4E7BE4B5A25 @default.
- Q90874109 P2093 Q90874109-52608100-5FF3-46DE-B12D-29E415881C62 @default.
- Q90874109 P2093 Q90874109-8111830D-0D17-449C-AFEF-7CC1D90DF73D @default.
- Q90874109 P2093 Q90874109-875AD117-2342-451C-87DE-C383BA6EC333 @default.
- Q90874109 P2093 Q90874109-8C38682C-33FF-40FF-8599-39375FE3781A @default.
- Q90874109 P2093 Q90874109-AC013D22-ADF0-4133-A517-7285CAE2F6C8 @default.
- Q90874109 P2093 Q90874109-C11C17C0-C541-4E96-8EA1-51FA73068521 @default.
- Q90874109 P2093 Q90874109-D4F37994-E545-422A-9E44-460D73F9A82E @default.
- Q90874109 P2093 Q90874109-E076ECB8-C05C-4947-8372-AD2635409A3E @default.
- Q90874109 P2093 Q90874109-E9A72499-CD4B-4A1B-AD18-633A13D47306 @default.
- Q90874109 P2093 Q90874109-EEB18CA2-6A63-4607-A097-B31E2B3DA61A @default.
- Q90874109 P304 Q90874109-7E89E698-E94C-493D-8E24-C04958CEB181 @default.
- Q90874109 P31 Q90874109-EAE1EC97-A85F-4298-B6AE-D3C05E6007C1 @default.
- Q90874109 P356 Q90874109-AD0A19F8-5A42-4750-861F-653338C579FA @default.
- Q90874109 P478 Q90874109-CC68AD72-CA6F-41FE-AB52-D4233BC73385 @default.
- Q90874109 P50 Q90874109-04BD7645-6415-4DB5-B8AF-52E0B4DE81E3 @default.
- Q90874109 P50 Q90874109-13D340C8-B3D6-4971-9E57-0B484F19158F @default.
- Q90874109 P50 Q90874109-39B8E1DD-2FBD-457D-80E7-B942A02E8C5A @default.
- Q90874109 P50 Q90874109-F78F1C3C-805D-4868-AF02-65BD130D3F70 @default.
- Q90874109 P577 Q90874109-6A17483E-2541-4C43-9E07-FFCACFE4BED6 @default.
- Q90874109 P698 Q90874109-021715A4-D51A-498D-A6C8-3ACC90A9C14B @default.
- Q90874109 P921 Q90874109-007CE410-D4DD-44F1-8371-0EA4A9EBA9D4 @default.
- Q90874109 P356 J.EJCA.2018.06.034 @default.
- Q90874109 P698 30096704 @default.
- Q90874109 P1433 Q332260 @default.
- Q90874109 P1476 "Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial" @default.
- Q90874109 P2093 "Adil Daud" @default.
- Q90874109 P2093 "Ahmed Tarhini" @default.